An Assessment of the Permeation Enhancer, 1-phenyl-piperazine (PPZ), on Paracellular Flux Across Rat Intestinal Mucosae in Ussing Chambers

Current status of selected oral peptide technologies in advanced preclinical development and in clinical trials

(2016) T.A.S. Aguirre et al.   ADVANCED DRUG DELIVERY REVIEWS

The pH of Piperazine Derivative Solutions Predicts Their Utility as Transepithelial Permeation Enhancers

(2016) Nicholas G. Lamson et al.   MOLECULAR PHARMACEUTICS

Changes in intestinal barrier function and gut microbiota in high-fat diet-fed rats are dynamic and region dependent

(2015) M. Kristina Hamilton et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Future prospect of insulin inhalation for diabetic patients: The case of Afrezza versus Exubera

(2015) Moawia M. Al-Tabakha   JOURNAL OF CONTROLLED RELEASE

Evaluation of the effects of anti-motion sickness drugs on subjective sleepiness and cognitive performance of healthy males

(2013) AP Weerts et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Evaluation of alkylmaltosides as intestinal permeation enhancers: Comparison between rat intestinal mucosal sheets and Caco-2 monolayers

(2012) Signe Beck Petersen et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Adherent-Invasive Escherichia coli Induce Claudin-2 Expression and Barrier Defect in CEABAC10 Mice and Crohnʼs Disease Patients§

(2011) Jeremy Denizot et al.   INFLAMMATORY BOWEL DISEASES

Searching for multi-target antipsychotics: Discovery of orally active heterocyclic N-phenylpiperazine ligands of D2-like and 5-HT1A receptors

(2010) Gilda Neves et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Molecular modeling study of 4-phenylpiperazine and 4-phenyl-1,2,3,6-tetrahydropyridine derivatives: A new step towards the design of high-affinity 5-HT1A ligands

(2009) Sébastien Dilly et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Evaluation of intestinal absorption enhancement and local mucosal toxicity of two promoters. I. Studies in isolated rat and human colonic mucosae

(2009) Sam Maher et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Discovery Process and Pharmacological Characterization of 2-(S)-(4-Fluoro-2-methylphenyl)piperazine-1-carboxylic Acid [1-(R)-(3,5-Bis-trifluoromethylphenyl)ethyl]methylamide (Vestipitant) as a Potent, Selective, and Orally Active NK1Receptor Antagonist

(2009) Romano Di Fabio et al.   JOURNAL OF MEDICINAL CHEMISTRY

Increased Intestinal Permeability in Rats Subjected to Traumatic Frontal Lobe Percussion Brain Injury

(2009) Linda Feighery et al.   JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE

Mechanistic Analysis of Chemical Permeation Enhancers for Oral Drug Delivery

(2008) Kathryn Whitehead et al.   PHARMACEUTICAL RESEARCH

Serotonergic neurotransmission mediates hypothermia induced by the N-phenylpiperazine antipsychotic prototypes LASSBio-579 and LASSBio-581

(2007) Gilda Neves et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR